Skip to main content

BIO-TECHNE Corp cash flow statement

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

In fiscal 2026 (the year to 30 Jun 2026), BIO-TECHNE Corp generated $292.1M of operating cash flow and $263.2M of free cash flow, after $28.85M of capital expenditure.

From BIO-TECHNE Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

BIO-TECHNE Corp cash flow statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Net income$105.2M$109.8M$112.3M$112.3M$112.6M$110.9M$107.7M$104.5M$76.09M$126.2M$96.07M$229.3M$140.4M$272.1M$285.3M$168.1M$73.36M$181.8M$172.0M
Depreciation & amortization$7.77M$8.13M$8.70M$12.47M$12.32M$19.18M$37.23M$42.76M$60.04M$64.46M$78.17M$82.74M$87.75M$101.1M$107.2M$111.7M$109.9M$97.36M$96.75M
Stock-based compensation$1.50M$1.10M$1.10M—$1.86M$3.52M$5.96M$9.43M$14.63M$28.24M$32.28M$32.37M$48.98M$42.18M$39.23M$38.04M$40.83M$41.37M$43.09M
Operating cash flow$111.3M$111.3M$127.2M$126.7M$123.6M$136.8M$139.4M$144.2M$143.7M$170.4M$181.6M$205.2M$352.2M$325.3M$254.4M$299.0M$287.6M$292.1M$337.6M
Operating cash flow margin42.2%41.4%43.9%40.3%39.8%38.2%30.8%28.9%25.5%26.5%25.4%27.8%37.8%29.4%22.4%25.8%23.6%24.0%27.5%
Capital expenditures$6.56M$4.64M$3.63M$6.02M$22.45M$13.82M$19.91M$16.90M$15.18M$20.93M$25.41M$51.74M$44.30M$44.91M$38.24M$62.88M$31.01M$28.85M$29.40M
Acquisitions$0.00$0.00$131.8M$0.00$0.00$109.2M$420.1M$91.42M$253.8M$67.85M$289.5M$0.00$225.4M—$101.2M$169.7M———
Free cash flow$104.8M$106.6M$123.6M$120.7M$101.1M$122.9M$119.5M$127.3M$128.5M$149.4M$156.2M$153.5M$307.9M$280.4M$216.1M$236.1M$256.6M$263.2M$308.2M
Free cash flow margin39.7%39.6%42.6%38.4%32.6%34.4%26.4%25.5%22.8%23.2%21.9%20.8%33.1%25.4%19.0%20.4%21.0%21.7%25.1%
Free cash flow per share$0.69$0.71$0.83$0.82$0.69$0.83$0.80$0.85$0.86$0.98$1.00$0.97$1.90$1.71$1.34$1.47$1.61$1.68$1.96
Dividends paid$28.19M$38.39M$39.69M$41.02M$43.46M$45.39M$47.11M$47.61M$47.33M$47.97M$48.36M$48.90M$49.62M$50.19M$50.28M$50.42M$50.39M$49.92M$50.03M
Gross share repurchases$90.63M$14.97M$1.94M$23.60M$1.82M$0.00$0.00——$0.00$15.40M$50.11M$43.18M$160.9M$19.56M$80.04M$275.7M$41.67M—
Stock issuance proceeds$953.0K$3.26M$4.79M$847.0K$1.10M$8.33M$9.73M$5.46M$5.26M$19.17M$37.95M$70.98M$65.09M$77.16M$29.81M$60.94M$51.74M$80.62M$93.30M
Net share repurchases$89.68M$11.71M−$2.85M$22.75M$716.0K−$8.33M−$9.73M−$5.46M−$5.26M−$19.17M−$22.55M−$20.87M−$21.91M$83.80M−$10.25M$19.11M$224.0M−$38.94M−$93.30M
Cash interest paid——————$1.54M$1.66M$7.45M$9.84M$21.50M$18.61M$13.58M$11.03M$8.37M$14.50M$18.95M$14.39M$12.22M
Free cash flow after SBC$103.3M$105.5M$122.5M—$99.24M$119.4M$113.5M$117.8M$113.9M$121.2M$123.9M$121.1M$258.9M$238.2M$176.9M$198.1M$215.7M$221.9M$265.1M

Quarterly

BIO-TECHNE Corp cash flow statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Net income$27.46M$49.05M$40.58M$33.59M$34.89M$22.59M−$17.70M$38.18M$38.00M$51.04M$54.64M$28.29M
Depreciation & amortization$27.80M$27.31M$28.06M$28.14M$27.08M$27.57M$27.11M$24.34M$24.71M$24.17M$24.14M$23.73M
Stock-based compensation$12.75M$8.13M$7.06M$10.18M$14.71M$11.39M$4.55M$11.68M$13.96M$10.49M$5.23M$13.41M
Operating cash flow$83.12M$80.99M$75.50M$63.89M$84.35M$41.12M$98.20M$27.59M$82.41M$86.66M$95.42M$73.11M
Operating cash flow margin30.5%26.7%24.7%22.1%28.4%13.0%31.0%9.6%27.9%27.8%29.7%24.4%
Capital expenditures$14.86M$16.44M$17.98M$9.17M$6.82M$10.12M$4.89M$5.36M$5.92M$9.09M$8.48M$5.92M
Acquisitions$3.28M$0.00$0.00——$0.00——————
Free cash flow$68.25M$64.55M$57.52M$54.72M$77.53M$31.00M$93.31M$22.22M$76.49M$77.58M$86.94M$67.20M
Free cash flow margin25.0%21.3%18.8%18.9%26.1%9.8%29.4%7.8%25.9%24.9%27.1%22.4%
Free cash flow per share$0.43$0.40$0.36$0.34$0.48$0.20$0.59$0.14$0.49$0.49$0.55$0.43
Dividends paid$12.56M$12.58M$12.63M$12.69M$12.74M$12.58M$12.39M$12.44M$12.47M$12.52M$12.48M$12.56M
Gross share repurchases—$0.00$0.00——$100.0M$100.1M$24.00K$0.00$0.00$41.65M—
Stock issuance proceeds$5.28M$18.33M$22.93M$25.10M$5.54M$14.87M$6.23M$23.50M$4.74M$29.96M$22.43M$36.18M
Net share repurchases−$5.28M−$18.33M−$22.93M−$25.10M−$5.54M$85.17M$93.83M−$23.47M−$4.74M−$29.96M$19.23M−$36.18M
Cash interest paid$4.08M$3.81M$2.11M$5.21M$4.63M$4.40M$4.72M$4.82M$3.99M$2.98M$2.60M$2.65M
Free cash flow after SBC$55.50M$56.41M$50.45M$44.53M$62.82M$19.61M$88.76M$10.54M$62.53M$67.08M$81.71M$53.79M

The main figures as JSON and plain text. See data and methodology.

TECH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.